Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Related structures:
AlphaFold database: E9B1N5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 203 | 207 | PF00656 | 0.453 |
CLV_NRD_NRD_1 | 191 | 193 | PF00675 | 0.385 |
CLV_NRD_NRD_1 | 279 | 281 | PF00675 | 0.514 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.424 |
CLV_PCSK_KEX2_1 | 272 | 274 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 279 | 281 | PF00082 | 0.485 |
CLV_PCSK_PC1ET2_1 | 272 | 274 | PF00082 | 0.497 |
CLV_PCSK_SKI1_1 | 104 | 108 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 117 | 121 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.476 |
DOC_CYCLIN_RxL_1 | 188 | 199 | PF00134 | 0.464 |
DOC_MAPK_gen_1 | 188 | 196 | PF00069 | 0.305 |
DOC_PP1_RVXF_1 | 253 | 259 | PF00149 | 0.496 |
DOC_PP1_RVXF_1 | 78 | 85 | PF00149 | 0.275 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.402 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.453 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.537 |
DOC_USP7_UBL2_3 | 103 | 107 | PF12436 | 0.583 |
LIG_Actin_WH2_2 | 88 | 105 | PF00022 | 0.522 |
LIG_AP2alpha_1 | 171 | 175 | PF02296 | 0.424 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.556 |
LIG_BRCT_BRCA1_1 | 47 | 51 | PF00533 | 0.417 |
LIG_BRCT_BRCA1_1 | 55 | 59 | PF00533 | 0.432 |
LIG_CaM_IQ_9 | 161 | 176 | PF13499 | 0.310 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.496 |
LIG_FHA_1 | 245 | 251 | PF00498 | 0.661 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.519 |
LIG_FHA_2 | 207 | 213 | PF00498 | 0.521 |
LIG_FHA_2 | 40 | 46 | PF00498 | 0.583 |
LIG_FHA_2 | 58 | 64 | PF00498 | 0.562 |
LIG_LIR_Gen_1 | 172 | 182 | PF02991 | 0.393 |
LIG_LIR_Gen_1 | 48 | 59 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 172 | 178 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.569 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.440 |
LIG_PDZ_Class_2 | 288 | 293 | PF00595 | 0.478 |
LIG_Pex14_2 | 171 | 175 | PF04695 | 0.405 |
LIG_SH2_CRK | 271 | 275 | PF00017 | 0.469 |
LIG_SH2_GRB2like | 257 | 260 | PF00017 | 0.462 |
LIG_SH2_SRC | 67 | 70 | PF00017 | 0.399 |
LIG_SH2_STAP1 | 150 | 154 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 193 | 196 | PF00017 | 0.424 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 257 | 260 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 264 | 267 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.575 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.414 |
LIG_TRAF2_1 | 214 | 217 | PF00917 | 0.505 |
LIG_TYR_ITIM | 269 | 274 | PF00017 | 0.467 |
LIG_WRC_WIRS_1 | 23 | 28 | PF05994 | 0.453 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.485 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.329 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.440 |
MOD_CK2_1 | 102 | 108 | PF00069 | 0.530 |
MOD_CK2_1 | 39 | 45 | PF00069 | 0.500 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.587 |
MOD_GlcNHglycan | 231 | 234 | PF01048 | 0.482 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.401 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.486 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.492 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.459 |
MOD_N-GLC_1 | 183 | 188 | PF02516 | 0.544 |
MOD_N-GLC_1 | 196 | 201 | PF02516 | 0.295 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.500 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.479 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.569 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.404 |
MOD_Plk_1 | 196 | 202 | PF00069 | 0.346 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.409 |
MOD_SUMO_for_1 | 113 | 116 | PF00179 | 0.457 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 271 | 274 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 87 | 90 | PF00928 | 0.447 |
TRG_ER_diArg_1 | 190 | 192 | PF00400 | 0.398 |
TRG_ER_diArg_1 | 278 | 280 | PF00400 | 0.485 |
TRG_Pf-PMV_PEXEL_1 | 104 | 108 | PF00026 | 0.410 |
TRG_Pf-PMV_PEXEL_1 | 135 | 139 | PF00026 | 0.409 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P348 | Leptomonas seymouri | 22% | 67% |
A0A1X0NK28 | Trypanosomatidae | 34% | 72% |
A0A3Q8IG21 | Leishmania donovani | 73% | 70% |
A0A3Q8IIE7 | Leishmania donovani | 72% | 94% |
A0A3S7WQB3 | Leishmania donovani | 22% | 70% |
A0A422NQZ1 | Trypanosoma rangeli | 33% | 71% |
A4H6C6 | Leishmania braziliensis | 23% | 100% |
A4HJ56 | Leishmania braziliensis | 61% | 67% |
A4HTM7 | Leishmania infantum | 22% | 70% |
A4I6H9 | Leishmania infantum | 72% | 70% |
E9AHL0 | Leishmania infantum | 73% | 94% |
E9AMG1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 70% |
E9B1M8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
E9B1N6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 70% |
Q4Q6H8 | Leishmania major | 69% | 67% |
Q4Q6I6 | Leishmania major | 68% | 100% |
Q4QI82 | Leishmania major | 23% | 100% |